Merck Serono, Galderma breach ABPI code; Health Canada hands-off when regulating DTC drug ads, study finds;

> The Prescription Medicines Code of Practice Authority has found Merck KGaA's Serono unit and Galderma guilty of the most serious breach of the ABPI Code of Practice. Report

> Health Canada is indifferent to enforcing its own regulations when it comes to prescription drug ads targeted to health consumers, a new study has found. Report

> If the total number of new HCV patients doubles in 2014, there will be room for the forthcoming crop of hep C competitors, a Morgan Stanley analyst says. More

> Sun Pharma may retire the Ranbaxy brand while retaining sub-brands like Volini and Revital. Report

> Novartis' ($NVS) Sandoz biosimilar copy of Amgen's ($AMGN) Neupogen showed similar efficacy in a late-stage study. Report

> Barnum Communications founder Dr. James Barnum and Lewis and Gace cofounder Francis Gace have been selected as 2015 inductees into the Medical Advertising Hall of Fame. Story

And Finally... BlackBerry is targeting doctors and nurses who use its smartphones with its first healthcare app. More

Suggested Articles

Esperion's Nexletol has had a rough road to approval after safety concerns nearly derailed its quest. But an FDA nod has the drug ready for market.

Nerlynx is already struggling in its extended adjuvant breast cancer setting, and new entrants from Daiichi-AZ and SeaGen could pressure it elsewhere.

Eli Lilly is joining Team USA as an official sponsor for the first time, backing Olympic and Paralympic athletes headed to Tokyo this summer.